DDrare: Database of Drug Development for Rare Diseases

Searched query = "Progressive myoclonus epilepsy", "Unverricht-Lundborg disease", "Lafora disease", "Benign adult familial myoclonus epilepsy", "BAFME"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide; (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide; BRIVARACETAM; BRV 2.5 mg; BRV 25 mg; BRV 50 mg; Brivaracetam; Brivaracetam 25 mg; Brivaracetam 50 mg; Intravenous immunoglobulin; ROPINIROLE HYDROCHLORIDE; Requip; Ropinirole; Ropinirole hydrochloride; Ucb 34714

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03351569 (ClinicalTrials.gov)	December 9, 2015	27/10/2017	Intravenous Immunoglobulin for Unverricht-Lundborg Disease.	Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial.	Unverricht-Lundborg Disease	Drug: Intravenous immunoglobulin	Azienda Socio Sanitaria Territoriale di Mantova	NULL	Active, not recruiting	18 Years	25 Years	Male	1	Phase 3	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03351569
(ClinicalTrials.gov)

December 9, 2015

27/10/2017

Intravenous Immunoglobulin for Unverricht-Lundborg Disease.

Intravenous Immunoglobulin for Unverricht-Lundborg Disease: Single-patient Trial.

Unverricht-Lundborg Disease

Drug: Intravenous immunoglobulin

Azienda Socio Sanitaria Territoriale di Mantova

NULL

Active, not recruiting

18 Years

25 Years

Male

Phase 3

NULL